Lindt & Spruengli faces investor pressure for board reforms following the CEO's removal due to pricing strategy failures amidst rising cocoa costs. Soaring raw material costs continue to strain confectionery margins, while emerging consumer trends like weight-loss drugs pose additional demand risks for premium chocolate brands. Governance instability threatens Lindt's ability to meet growth targets, potentially impacting operational efficiency and investor confidence in the near term.
2 articles
Lindt & Spruengli investors demand board reforms following CEO ouster caused by pricing errors linked to soaring cocoa costs. Governance concerns and market challenges, including weight-loss drug impa
Lindt & Spruengli reduced its 2026 organic sales growth forecast to 0-2%, citing high cocoa prices and weak demand worsened by a European heatwave. The company maintained operating margin targets whil
ChemBrief